First Page | Document Content | |
---|---|---|
Date: 2006-10-02 13:06:37Immunology Multiple sclerosis IDEC Monoclonal antibodies UCB Medicine Immune system Natalizumab Therapies under investigation for multiple sclerosis Immunosuppressants Biogen Idec CDP323 | Add to Reading ListSource URL: hugin.infoDownload Document from Source WebsiteFile Size: 98,94 KBShare Document on Facebook |
BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, biDocID: 1rrNB - View Document | |
Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2DocID: 1rmwo - View Document | |
EAP Reimbursement Criteria for Frequently Requested DrugsDocID: 1rhhE - View Document | |
UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include: Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certolDocID: 1rakB - View Document | |
TABLE OF CONTENTS INTRODUCTION 2DocID: 1qY7G - View Document |